The informative value of CD3+CD4+ and CD3+CD8+ T-cell count and cHIS scale as predictors of severe COVID-19 when using interleukin-6 receptor blockers in the in-hospital setting.

Published in: Terapevticheskii arkhiv (2022)

The main result of the study is the definition of target groups of patients with community-acquired SARS-CoV-2 pneumonia for the IL-6R-blockers, considering the timing of their effective use in real clinical practice.

Keyphrases

sars cov
clinical practice
angiotensin converting enzyme
healthcare
respiratory syndrome coronavirus
coronavirus disease
early onset
emergency department
intensive care unit
adverse drug
peripheral blood
acute care
binding protein